Octopus IHT AIM VCT plc ("the Company")
2 November 2009
Interim Management Statement
For the period from 1 June 2009 to 28 October 2009
In accordance with Rule 4.3 of the UK Listing Authority's Disclosure
and Transparency rules, Octopus IHT AIM VCT plc presents an Interim
Management Statement for the period 1 June 2009 to 28 October 2009,
being the latest weekly valuation prior to the date of this
statement.
Financial Summary
As at 28 As at 31 May As at 30
October 2009 2009 November 2008
Total net assets (£'000s) 11,1301 16,726 16,049
Net asset value per share
("NAV") 71.0p 68.4p 64.6p
Cumulative dividend - paid
and proposed since launch 7.4p 7.4p 6.4p
Note: 1) On 24 June 2009, B shareholders accounting for 8,141,325 B
shares exited the VCT as part of the planned distribution in specie.
The assets of your Company were reduced accordingly.
Investment performance
The NAV has risen by just under 4% over the period under review to 28
October 2009. As at 28 October 2009, the NAV per A Ordinary share
was 71.0p compared to a NAV at 31 May 2009 of 68.4p. This was against
the background of a continued recovery in the market in general, but
it is only relatively recently that the rise in confidence has begun
to trickle down to the share prices of the smallest companies in
which your fund invests. There have also been some signs that other
corporates are recognising the value still available in smaller
company shares. In the period an all share offer has been received
from Chime for Essentially Group, a cash offer for Claimar and
Research Now has recently announced an agreed bid by an American
competitor.
The market for VCT qualifying issues, however, has been slower than
expected. New issues remain very rare, although there are signs that
this market may start to recover over the next six months. While we
had hoped for a number of attractively priced opportunities to invest
in existing companies replacing bank debt or funding expansion, these
have not really materialised in the VCT qualifying space, with most
opportunities either being much smaller or much bigger. However,
your Company is currently comfortably above the HM Revenue & Customs
requirement for qualifying holdings and has liquid funds giving
plenty of scope for participating in these opportunities when they
appear, as we still expect them to do.
Investment Activity
The following new investments have been completed since 31 May 2009:
23 July, investment of £120,000 was made in Innovision
23 September, investment of £101,000 in Omega Diagnostics
13 October, investment of £310,000 in Clarity Commerce Solutions
26 October, investment of £195,000 in Colliers,
28 October, investment of £242,000 in Bond International Software.
The first three of these are VCT qualifying holdings and the last two
are non qualifying holdings in companies where we see good recovery
prospects.
With regard to disposals, during the period the investments in
Bglobal and Neuropharm were fully disposed of at a loss to original
cost, with partial disposals to take profits in Advanced Computer
Software and Animalcare Group. Claimar Care Group was disposed of
after a cash offer of 39p per share by Housing 21 was accepted by
shareholders.
Ten largest equity holdings as at 28 October 2009
Carrying value as a
% of total
Carrying investments and
Investee Company Sector value £'000 cash
IS Pharma plc
(formerly Maelor Pharmaceuticals &
plc) Biotechnology 807 7.3%
Advanced Computer Software & Computer
Software plc Services 757 6.8%
Research Now Plc Media 630 5.7%
Melorio plc Support services 552 5.0%
AnimalCare Group
plc Food Producers 505 4.5%
Brulines Holdings
plc Support services 430 3.9%
Vertu Motors plc General retailers 351 3.2%
Managed Support
Services plc Support services 345 3.1%
Pressure Engineering &
Technologies plc Machinery 338 3.0%
Tasty plc Travel and leisure 334 3.0%
B Share Conversion and Distribution in Specie
A circular was posted to all B shareholders in May giving those
shareholders the option to proceed with the Distribution in Specie
whereby they would end up with a portfolio of underlying holdings
from the VCT as set out in the original prospectus or the chance to
elect to convert to A Ordinary Shares and remain in the VCT. A
General Meeting was held on 3 June for B shareholders to approve the
process and the resolution was passed. Of the 17,125,400 B Ordinary
Shares in existence at the start of this process, 8,984,075 converted
into A Ordinary Shares, the assets in the remaining B Ordinary Share
portfolio have now been distributed to the underlying shareholders.
Dividends
It is your Board's policy to strive to maintain a regular dividend
flow where possible and this primarily relies on the level of
profitable realisations and available cash reserves. For the six
months ended 31 May 2009, the Board declared an interim dividend of 1
p per A Ordinary Share, payable from capital reserves. Now that the
Distribution in Specie has been finalised, HMRC approval is being
sought and your dividend should be paid shortly. An announcement
will be made in advance informing shareholders of the record and
payment dates
Buybacks
During the period 415,275 A Ordinary shares were bought back at a
weighted average price of 60.5p.
Material events and transactions
The Board is not aware of any significant event or transaction which
has occurred between 28 October 2009 and the date of publication of
this statement.
For further information please contact:
Kate Tidbury / Andrew Buchanan - Fund Managers
Octopus Investments Limited - 0800 316 2347
ENDS
---END OF MESSAGE---
This announcement was originally distributed by Hugin. The issuer is
solely responsible for the content of this announcement.
AI Summary Disclaimer BETA
The content you are viewing has been generated or assisted by artificial
intelligence (AI). While efforts are made to ensure accuracy and clarity, AI-generated text may
contain inaccuracies, outdated information, or subjective interpretations. This content is intended
for general informational purposes only and should not be considered professional advice or factual
confirmation.
We encourage you to independently verify any information provided,
especially if it will be relied upon for making decisions or taking action. Any reliance you place
on this material is strictly at your own risk. The AI system that produced this content cannot
assess the specifics of individual circumstances, and results may vary based on context and
individual needs.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.
Create an Account
Create your FREE account to receive personalised announcements, watchlists, market updates, investment insights and new features.
Personalise your experience
Tell us a little about yourself to receive personalised content, announcements and relevant investment opportunities.